ImmunOs Therapeutics

formerly Immunos

ImmunOs Therapeutics is a biotech company in Basel, Switzerland, founded in 2014. It has raised $102.5M across 3 rounds, most recently an $11.0M Series C in September 2024.

Harnessing the Immune System to treat Cancer and Inflammatory Diseases - Immunostherapy

Headquarters
Basel
Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$102.5M
Last Round
$11.0M Series CSep 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.

About

ImmunOs Therapeutics AG develops novel therapeutics that harness the immune system to treat cancer and inflammatory diseases. The company works from an HLA-based technology platform with programs spanning immuno-oncology and inflammatory-disease pipelines. Its team brings expertise in drug development and commercialization in immunology, immunotherapy, and oncology, and its stated mission is to develop novel therapeutics that improve the lives of patients with serious diseases.

Summary

It lists 11–50 employees. It has raised $102.5M in total across 3 rounds, most recently a $11.0M Series C round in Sep 2024. Investors include Lightspeed Venture Partners, Gimv and Pfizer Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries CSep 2024
$11.0M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ImmunOs Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/immunos-therapeutics"><img src="https://indexed.vc/api/badge/company/immunos-therapeutics" alt="ImmunOs Therapeutics on Indexed.vc" width="260" height="76" /></a>